On Tuesday (June 8), pharmaceutical company Pfizer said that larger groups of children below the age of 12 will begin testing for their Covid-19 Vaccine in lower doses.
Advertisements
This study will involve 4,500 children in United States, Finland, Poland and Spain at more than 90 clinical sites the company added.
Pfizer said that 10 mg dose will be given to children aged 5 to 11, and 3 mg does will be given to children aged 6 months to 5 based on safety guidelines.
Data for these studies will be coming out from September onwards.